In patients with cystic fibrosis, treatment with elexacaftor-tezacaftor-ivacaftor significantly improves glycemic control with no new safety concerns. Medscape Medical News Source link : https://www.medscape.com/viewarticle/triple-therapy-boosts-glycemic-control-cystic-fibrosis-2025a1000n2d?src=rss Author : Publish date : 2025-09-02...
Read more









